A brain-penetrating cancer drug under development has also been shown to restore motor function in spinal injuries within four weeks by regenerating nerves.
Scientists have shown that when taken orally the drug, known as AZD1390, can block the body’s response to damaged DNA and so allows nerves to repair themselves, restoring sensory and motor functions.
The breakthrough comes weeks after the same research team from the University of Birmingham found that another drug being investigated can reduce damage after a spinal injury by blocking the inflammatory response.
